Insights from TAILORx and RxPONDER in Guiding Treatment in Early-Stage HR+ Breast Cancer
June 25th 2024
Expert breast oncologists examine adjuvant therapy approaches for early-stage hormone receptor-positive breast cancer, emphasizing the distinct treatment strategies and outcomes observed in pre- and post-menopausal patient populations.